Recent findings from scientists at St. Jude Children’s Research Hospital are showing promise for assessing cardiomyopathy risk in childhood cancer survivors
The new platform will help researchers better understand cell-to-cell interactions in tumor microenvironments, benefitting future development of targeted cancer therapies
Per the NIH, head and neck cancer makes up about 5 percent of all cancers worldwide and 3 percent of all malignancies in the US
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.